Skip to content
Navigate to homepage - Cerba Research
Resource Library

Created:

Guilfoyle K, et al. Protective efficacy of a polyvalent influenza A DNA vaccine against both homologous (H1N1pdm09) and heterologous (H5N1) challenge in the ferret model.

Resource Library

Created:

Ryu DK, et al. Therapeutic effect of CT-P59 against SARS-CoV-2 South African variant.

Resource Library

Created:

Zwittink RD, et al.The vaginal microbiota in the course of bacterialvaginosis treatment.

Resource Library

Created:

McMillan CLD, et al. Development of molecular clamp stabilized hemagglutinin vaccines for Influenza A viruses.

Resource Library

Created:

van der Zee RP, et al. Cancer risk stratificationof anal intraepithelial neoplasia in human immunodeficiency virus-positive Menby validated methylation markers associated with progression to cancer.

Resource Library

Created:

Sierra MS, et al. Risk factors for non-human papillomavirus (HPV) Type 16/18 cervicalInfections and associated lesions among HPV DNA-negative women vaccinated against HPV-16/18 in the Costa Rica vaccine trial.

Resource Library

Created:

Ryu DK, et al. The in vitro and in vivo efficacy of CT-P59 against Gamma, Delta and its associated variants of SARS-CoV-2.

Resource Library

Created:

Watterson D, et al. Preclinical development of a molecular clamp-stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2.

Resource Library

Created:

Gosens KCM, et al. HPV vaccination to prevent recurrence of anal intraepithelial neoplasia in HIV+MSM.

Resource Library

Created:

Bonde J, et al. Methylationmarkers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirusscreen positive women: A large European multicenter study.